Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Keating

Showing results (11-20 of 188) with videos related to

Pageof 19
Sort By:
Clinical Orthopaedics and Related Research|December 4, 2003
Patella fracture after post total knee replacementsE Michael Keating, Gail Haas, John B Meding
Instructional Course Lectures|June 14, 2005
Blood management in total joint arthroplastyThomas P Sculco, Andrea Baldini, E Michael Keating
American Journal of Hematology|November 26, 2002
Chronic lymphocytic leukemia presenting in association with aplastic anemiaJeffrey A Zonder, Michael Keating, Charles A Schiffer
Archives of Pathology & Laboratory Medicine|April 24, 2003
CD79b expression in chronic lymphocytic leukemia. Association with trisomy 12 and atypical immunophenotypeEllen Schlette, L Jeffrey Medeiros, Michael Keating, et al.
Journal of Blood Medicine|January 28, 2012
Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)Aref Al-Kali, William Wierda, Michael Keating, et al.
Asian Journal of Andrology|December 19, 2007
Ventral phalloplastyJorge Caso, Michael Keating, Alejandro Miranda-Sousa, et al.
Clinical Orthopaedics and Related Research|September 21, 2010
Acetabular UHMWPE survival and wear changes with different manufacturing techniquesJohn B Meding, E Michael Keating, Kenneth E Davis
Leukemia Research|November 26, 2015
Isolation of a novel chronic lymphocytic leukemic (CLL) cell line and development of an in vivo mouse model of CLLJoshua Kellner, William Wierda, Elizabeth Shpall, et al.
Leukemia Research|July 4, 2008
Pregnancy in a patient with hypereosinophilic syndromePatricia Ault, Jorge Cortes, Alice Lynn, et al.
Leukemia & Lymphoma|October 10, 2009
Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategyDeborah A Thomas, Farhad Ravandi, Michael Keating, et al.
Pageof 19

Showing results (11-20 of 188) with videos related to

Sort By:
Pageof 19
Clinical Orthopaedics and Related Research|December 4, 2003
Patella fracture after post total knee replacementsE Michael Keating, Gail Haas, John B Meding
Instructional Course Lectures|June 14, 2005
Blood management in total joint arthroplastyThomas P Sculco, Andrea Baldini, E Michael Keating
American Journal of Hematology|November 26, 2002
Chronic lymphocytic leukemia presenting in association with aplastic anemiaJeffrey A Zonder, Michael Keating, Charles A Schiffer
Archives of Pathology & Laboratory Medicine|April 24, 2003
CD79b expression in chronic lymphocytic leukemia. Association with trisomy 12 and atypical immunophenotypeEllen Schlette, L Jeffrey Medeiros, Michael Keating, et al.
Journal of Blood Medicine|January 28, 2012
Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)Aref Al-Kali, William Wierda, Michael Keating, et al.
Asian Journal of Andrology|December 19, 2007
Ventral phalloplastyJorge Caso, Michael Keating, Alejandro Miranda-Sousa, et al.
Clinical Orthopaedics and Related Research|September 21, 2010
Acetabular UHMWPE survival and wear changes with different manufacturing techniquesJohn B Meding, E Michael Keating, Kenneth E Davis
Leukemia Research|November 26, 2015
Isolation of a novel chronic lymphocytic leukemic (CLL) cell line and development of an in vivo mouse model of CLLJoshua Kellner, William Wierda, Elizabeth Shpall, et al.
Leukemia Research|July 4, 2008
Pregnancy in a patient with hypereosinophilic syndromePatricia Ault, Jorge Cortes, Alice Lynn, et al.
Leukemia & Lymphoma|October 10, 2009
Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategyDeborah A Thomas, Farhad Ravandi, Michael Keating, et al.
Pageof 19